An observational study in Outcome Assessment, sponsored by Mead Johnson Nutrition. Active, not recruiting at 1 site in Thailand. Open to participants aged Up to 120 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-21.
Sponsored by Mead Johnson Nutrition (part of Reckitt) · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this observational study is to examine national trends in mode of delivery and to assess associations between cesarean section and early-life health outcomes using routinely collected health data in Thailand. The study includes mother-infant dyads delivering in public hospitals across Thailand.
The main questions it aims to answer are:
Is cesarean delivery associated with increased risk of adverse neonatal outcomes compared with vaginal delivery?
Is cesarean delivery associated with differences in early-life healthcare utilization and breastfeeding outcomes during the first year of life?
Researchers will compare infants born by cesarean section with infants born by vaginal delivery to evaluate differences in neonatal morbidity, healthcare utilization, and breastfeeding patterns.
Participants will not receive any intervention. The study involves secondary analysis of de-identified national health administrative and clinical data, including delivery records and linked maternal and infant health outcomes.
Mead Johnson Nutrition is the lead sponsor of 58 studies on the registry; 1 is open to participants now.
First submitted after Mead Johnson Nutrition became part of Reckitt.
Counted across the registry records on this site, refreshed daily.
This study includes mother-infant dyads identified retrospectively from routinely collected, de-identified national health administrative and clinical data from public hospitals in Thailand.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Mother-infant dyads in which delivery occurred by cesarean section. This observational cohort is identified retrospectively using routinely collected, de-identified national health data. No intervention is assigned.
Mother-infant dyads in which delivery occurred by vaginal birth. This observational cohort is identified retrospectively using routinely collected, de-identified national health data. No intervention is assigned.
Neonatal health outcomes associated with mode of delivery
Comparison of neonatal health outcomes, including birth asphyxia, neonatal infection, respiratory complications, and low birth weight, between infants born by cesarean section and vaginal delivery using routinely collected national health data.
Time frame: Birth to 28 days of life
Early-life healthcare utilization during infancy
Frequency of healthcare utilization, including outpatient visits, emergency department visits, hospital admissions, and antibiotic use among infants by mode of delivery.
Time frame: Birth to 12 months of age
Breastfeeding outcomes by mode of delivery
Rates of exclusive and any breastfeeding among infants born by cesarean section compared with vaginal delivery, assessed using routinely collected health and nutrition records.
Time frame: Birth to 12 months of age
Temporal and geographic trends in cesarean delivery rates
Trends in cesarean section rates across regions, hospital levels, and time periods using national health administrative data.
Time frame: Jan 2015 to Dec 2025
Plan to share: No
No publications or documents are linked to this record.
Started Apr 2026 (actual). Primary completion is estimated for Dec 2026, 8 months after the start.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 21, 2026: start Mar 2026 → Apr 2026, primary completion May 2026 → Dec 2026 and completion Dec 2026 → Mar 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.